Paragraph 3 Provision relating to critical use permitsF1I1
This paragraph applies where—
before IP completion day, the United Kingdom competent authority granted a permit under the first subparagraph of Article 55(1) of Regulation (EU) No 528/2012 for a period not exceeding 180 days, and
on receipt of a reasoned request from the United Kingdom competent authority, the Commission granted an extension of that permit under the third subparagraph of Article 55(1) of Regulation (EU) No 528/2012 until IP completion day.
The extension referred to in paragraph (1)(b) is to be taken as having been granted for a period of 550 days from the date when the Commission granted the extension referred to.
Annotations
Textual amendments
- F1
Sch. 4 inserted (31.12.2020 immediately before IP completion day) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 4
Commencement
- I1
Sch. 4 para. 3 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)